98%
921
2 minutes
20
Chordoma is a rare tumor that arises from chordal tissue during fetal life. Recently, the concept of poorly differentiated chordoma, a subtype of chordoma characterized by loss of / with a poorer prognosis than conventional chordomas, was established. It predominantly occurs in children and is rare in adults. Here, we report a rare adult case of poorly differentiated chordoma of the skull base with a unique course that rapidly systemically metastasized and had the shortest survival time of any adult chordoma reported to date. The patient was a 32-year-old male with a chief complaint of diplopia. MRI showed a widespread neoplastic lesion with the clivus as the main locus. Endoscopic extended transsphenoidal tumor resection was performed. Pathological findings showed that the tumor was malignant, and immunohistochemistry revealed a Ki-67 labeling index of 80%, diffusely positive brachyury, and loss of expression. The final diagnosis was poorly differentiated chordoma. Postoperatively, the residual tumor in the right cavernous sinus showed rapid growth. The patient was promptly treated with gamma knife three fractions. The residual tumor regressed, but the tumor developed systemic metastasis in a short period, and the patient died seven months after diagnosis. This report of a rapidly progressing and fatal adult poorly differentiated chordoma shows the highest Ki-67 labeling index reported to date. Prompt multidisciplinary treatment should be considered when the Ki-67 labeling index is high.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10764176 | PMC |
http://dx.doi.org/10.7759/cureus.51605 | DOI Listing |
Sci Adv
September 2025
Division of Applied Functional Genomics, German Cancer Research Center (DKFZ), Heidelberg, Germany.
The embryonic transcription factor TBXT (brachyury) drives chordoma, a spinal neoplasm without effective drug therapies. TBXT's regulatory network is poorly understood, and strategies to disrupt its activity for therapeutic purposes are lacking. We developed designed ankyrin repeat proteins that block TBXT-DNA binding (T-DARPins).
View Article and Find Full Text PDFCancers (Basel)
August 2025
Department of Neurosurgery, University of Ulm, Lindenallee 2, 89312 Günzburg, Germany.
: Pituitary tumors account for over 90% of all sellar region masses. However, a spectrum of rare neoplastic, inflammatory, infectious, and vascular lesions-benign and malignant-can arise in the intra- and parasellar compartments and clinically and radiologically mimic PitNETs. We report a cohort of 47 such rare and cystic midline intracranial lesions, emphasizing their distinctive morphological, clinical, and imaging features and the personalized treatment strategies applied.
View Article and Find Full Text PDFClin Case Rep
August 2025
Department of Radiation Oncology Homi Bhabha Cancer Hospital, Homi Bhabha National Institue Varanasi India.
Poorly differentiated chordoma is a very unique type of chordoma with a particularly aggressive clinical course and high metastatic potential. It almost exclusively affects children and young adolescents. Unlike conventional chordomas, poorly differentiated chordomas cannot be well controlled with surgery and radiation therapy.
View Article and Find Full Text PDFSurg Pathol Clin
September 2025
Department of Pathology and Laboratory Medicine, Dartmouth Hitchcock Medical Center, Lebanon, NH 03756, USA; Geisel School of Medicine at Dartmouth, Hanover, NH 03755, USA. Electronic address:
Head and neck bone tumors carry unique clinical, imaging, morphologic, and prognostic features compared to their peripheral counterparts and warrant a multidisciplinary approach for optimizing diagnosis and patient care. This review explores tumors characteristic of the head and neck (nasal chondromesenchymal hamartoma and osteochondromyxoma), as well as those that occur in other sites but have distinct features in this region (conventional and mesenchymal chondrosarcoma, osteosarcoma, and chordoma). Embryologic development and anatomic complexity of this region affect diagnostic considerations and patient management.
View Article and Find Full Text PDFNeuropathology
August 2025
Department of Pathology, Agilus Diagnostics, Fortis Memorial and Research Hospital (FMRI), Gurugram, India.
Dedifferentiated chordoma (DDC) is a rare subtype of chordoma, having a biphasic appearance, and is characterized by conventional chordoma juxtaposed with a high-grade sarcoma. The high-grade component varies from pleomorphic to fibrosarcomatous type. Several studies have been published in the literature highlighting the genetic mutations associated with conventional and poorly differentiated chordoma, however only one study has been published in the literature that included four cases of DDCs and has shown genetic alterations in p53, PTEN, RB, CDKN2A, and TERT promoter genes.
View Article and Find Full Text PDF